| ID | Name | CAS | Properties |
logPoct/wat |
| 20-108-9 |
2,5-Dichlorothiophene-3-sulphonyl chloride
|
|
2 | 2.982 |
| 20-368-1 |
Dihydrodaidzein (keto) mono-7-d9-TMS
|
|
2 | 3.965 |
| 20-407-7 |
Silane, diphenylpentyloxy(2,4,4-trimethylpentyloxy)-
|
|
2 | 5.539 |
| 20-460-8 |
Silane, diethyldi(6-ethyloct-3-yloxy)-
|
|
2 | 8.492 |
| 20-514-8 |
Glycine, N-(1-oxopropyl)-, trimethylsilyl ester
|
|
2 | 0.891 |
| 21-003-4 |
Silane, diethyl(2,5-dimethylphenoxy)heptyloxy-
|
|
2 | 6.151 |
| 21-036-8 |
Oxaloacetic acid, MO TBDMS # 1
|
|
2 | 6.989 |
| 21-040-3 |
2,2,2-Trichloroethanol, bromomethyldimethylsilyl ether
|
|
2 | 3.512 |
| 21-131-2 |
Silane, diethyl(2,4-dichlorophenoxy)heptyloxy-
|
|
2 | 6.841 |
| 21-167-3 |
7«beta»,13-diOH-kaurenolide, TMS
|
|
2 | 6.295 |
| 21-449-0 |
1,3-Benzenedimethanethiol, S-(tert-butyldimethylsilyl)-
|
|
2 | 5.355 |
| 21-685-8 |
16«alpha»-Hydroxyetiocholanolone(I), MO TMS
|
|
2 | 7.082 |
| 21-935-0 |
3-Deoxy-ribo-hexaric acid, TMS
|
|
2 | 5.793 |
| 22-188-9 |
2-Hydroxy-3-methylvaleric acid, TBDMS
|
|
2 | 2.942 |
| 22-292-3 |
5-«alpha»-Androstan-3-one, TMS
|
|
2 | 6.764 |
| 22-426-4 |
Octaethyl-porphyrin, Si-(OTBDMS)2-derivative
|
|
2 | 11.827 |
| 22-715-3 |
Silane, diethylhexadecyloxy(2,4,5-trichlorophenoxy)-
|
|
2 | 11.005 |
| 22-975-5 |
Benzimidazole, 4,7-dibromo-2-(trifluoromethyl)-
|
4228-97-1 |
2 | 3.625 |
| 23-102-2 |
PGA1, MO-TMS, isomer # 1
|
|
2 | 7.866 |
| 23-205-8 |
«beta»-D(-)-Lyxopyranose, tetrakis(trimethylsilyl) ether
|
|
2 | 4.854 |
| 23-388-6 |
P-phenylazo carbanilic acid, tetrahydrolinalool ester
|
95293-43-9 |
2 | 7.645 |
| 23-442-5 |
1-Diphenylethenylsilyloxy-3-methylbut-2-ene
|
|
2 | 3.454 |
| 23-617-1 |
Silane, diphenyl(cis-4-methylcyclohexyloxy)hexyloxy-
|
|
2 | 5.435 |
| 23-680-1 |
2-Phenoxy-6-benzoyl pyrazine phenylhydrazone
|
|
2 | 5.133 |
| 23-781-9 |
Dihydrodaidzein (enol) mono-4-d9, TMS
|
|
2 | 7.226 |
| 23-790-9 |
Silane, dimethyl(2,5-dimethylphenoxy)isohexyloxy-
|
|
2 | 4.837 |
| 23-975-4 |
Silane, dimethyl(2,5-dimethylphenoxy)dodecyloxy-
|
|
2 | 7.322 |
| 24-136-4 |
Silane, dimethyl(3,5-difluorophenoxy)isobutoxy-
|
|
2 | 3.718 |
| 24-138-2 |
(2-(Trifluoromethyl)phenyl)methanol, dimethylpentafluorophenylsilyl ether
|
|
2 | 5.030 |
| 24-183-2 |
2-Nitramino-1,3,4-thiadiazole
|
26947-66-0 |
2 | 0.142 |
| 24-184-1 |
Benzimidazole, 4,7-dichloro-2-(trifluoromethyl)-
|
4228-89-1 |
2 | 3.407 |
| 24-202-0 |
Purine, 6-hydroxy-8-hydroxymethyl, TMS
|
|
2 | 2.436 |
| 24-240-8 |
Silane, dimethyl(2,5-dichlorophenyloxy)undecyloxy-
|
|
2 | 7.621 |
| 24-279-6 |
Silane, diethylisohexyloxy(2-methylpent-3-yloxy)-
|
|
2 | 5.372 |
| 24-667-5 |
Fluoxymesterone, tris-TMS (3,5-diene)
|
|
2 | 8.827 |
| 24-734-0 |
Silane, diphenyltetradecyloxy(2,4,4-trimethylpentyloxy)-
|
|
2 | 9.050 |
| 24-753-9 |
3-Deoxy-erythro-pentaric acid, TMS
|
|
2 | 4.573 |
| 24-786-3 |
Silane, diphenylisohexyloxy(2,4,4-trimethylpentyloxy)-
|
|
2 | 5.785 |
| 25-088-7 |
4-Pyrimidinamine, 6-chloro-2-(methylthio)-
|
|
2 | 1.434 |
| 25-158-9 |
2,2'-Dithiodipyridine-1,1'-dioxide
|
|
2 | 1.753 |
| 25-183-1 |
Pyrrolidine, 1-(1-(4-trimethylsilyloxybenzoyl)ethyl)
|
|
2 | 3.567 |
| 25-218-2 |
D-galacturonic acid, TMS diethyldithioacetal derivative
|
|
2 | 8.077 |
| 25-353-2 |
Glycine, N-(2-propenoyl), bis-TMS
|
|
2 | 2.800 |
| 25-422-5 |
Silane, diethyl(2,6-dimethoxyphenoxy)heptyloxy-
|
|
2 | 5.552 |
| 25-461-2 |
1-Dimethylisopropylsilyloxy-3-methylbut-2-ene
|
|
2 | 3.584 |
| 25-538-7 |
Uridine, 3',5'-bis-O-TBDMS
|
|
2 | 2.725 |
| 25-568-4 |
GA4-diacid, methyl ester TMS ether
|
|
2 | 5.551 |
| 25-667-4 |
3-(tert-Butyldimethylsilyl)oxyiminobutan-2-one
|
|
2 | 2.973 |
| 25-686-3 |
Silane, diethyl(2,3-dimethylphenoxy)tetradecyloxy-
|
|
2 | 8.882 |
| 25-699-9 |
2,4-Dinitrophenylhydrazone of delta^3-cyclohexenylmethylketone
|
7350-34-7 |
2 | 3.647 |
| 25-984-2 |
Uridine, 2',5'-bis-O-TBDMS
|
|
2 | 2.725 |
| 26-001-1 |
2(1H)-Pyrimidinethione, 4,6-diamino-
|
1004-39-3 |
2 | -0.178 |
| 26-023-7 |
Trimethylsilyl 3,6-dichloropyridine-2-carboxylate
|
|
2 | 3.380 |
| 26-125-4 |
N-nitroso-n-(t-octyl)glycine
|
116435-37-1 |
2 | 2.271 |
| 26-135-3 |
L-(+)-Rhamnopyranose, tetrakis(trimethylsilyl) ether
|
|
2 | 5.243 |
| 26-291-0 |
Purine, 6-(2,2,2-trifluoroethoxy)-
|
73972-56-2 |
2 | 0.812 |
| 26-418-9 |
2-Deoxy-threo-pentaric acid, TMS
|
|
2 | 4.573 |
| 26-491-8 |
Silane, dimethyl(2,3-dimethylphenoxy)isohexyloxy-
|
|
2 | 4.837 |
| 26-630-3 |
1-(4-Methoxyphenyl)imidazoline-2-thione
|
17452-14-1 |
2 | 2.062 |
| 26-631-2 |
4,5-Dibromo-3(2H)-pyridazinone
|
5788-58-9 |
2 | 0.813 |
| 26-791-5 |
Disilicon tetrafluoride, compound with hydrogen sulfide
|
24628-35-1 |
2 | 1.032 |
| 27-271-1 |
Silane, diphenyl(cis-4-methylcyclohexyloxy)decyloxy-
|
|
2 | 6.996 |
| 27-450-2 |
Indole, 5-hydroxy-3-methyl, TMS
|
|
2 | 4.846 |
| 27-575-4 |
17-epi-4-Chlorodehydromethyltestosterone, 17-TMS
|
|
2 | 6.471 |
| 27-709-5 |
«beta»-N-Acetyl-D-glucosamine, TMS
|
|
2 | 4.317 |
| 27-722-0 |
9-Hydroxy-9-(2'-pyridyl)-xanthene
|
67916-68-1 |
2 | 3.471 |
| 27-748-2 |
Silane, diethyl(2,6-dimethoxyphenoxy)pentadecyloxy-
|
|
2 | 8.672 |
| 27-792-3 |
Ceramide 18:1/16:0 methaneboronate
|
|
2 | 10.743 |
| 27-967-9 |
GA12, 12-«alpha»-OH, Me-TMS
|
|
2 | 4.968 |
| 28-045-1 |
2-Trimethylsilyloxysebacic acid, bis(trimethylsilyl)- ester
|
|
2 | 5.693 |
| 28-194-6 |
Benzoic acid, 3-heptafluorobutyrylthio-, trimethylsilyl ester
|
|
2 | 5.130 |
| 28-288-2 |
2-Deoxy-D-galactose, ketol, TMS
|
|
2 | 5.089 |
| 28-297-2 |
Octylthiosulfuric acid, 2-amino-2-methyl-
|
|
2 | 1.151 |
| 28-310-6 |
PGA1, EO-TMS, isomer # 2
|
|
2 | 8.256 |
| 28-373-7 |
[13C]GA5 methyl ester TMS ether
|
|
2 | 4.004 |
| 28-451-0 |
Gluconic acid lactone, TMS # 2
|
|
2 | 4.424 |
| 28-463-7 |
(3,3,5-Trimethylcyclohexyl) 2-trimethylsilyloxybenzoate
|
|
2 | 5.272 |
| 28-694-1 |
FRUCTOSE-1,6-BISPHOSPHATE MEOX 7TMS
|
|
2 | 10.304 |
| 28-803-9 |
2,5-Difluorobenzyl alcohol, benzyldimethylsilyl ether
|
|
2 | 4.468 |
| 28-969-6 |
2,3-Diaminopropionic acid, ethoxycarbonylated, TBDMS
|
|
2 | 2.396 |
| 28-973-1 |
2-(2-Chlorophenoxy)ethanol, dimethylpentafluorophenylsilyl ether
|
|
2 | 4.543 |
| 28-978-6 |
4-Methyl-3-trimethylsilyloxy-N-trimethylsilylaniline
|
|
2 | 4.456 |
| 29-086-5 |
trans-Tetralin-2,3-diol, butylboronate
|
|
2 | 2.857 |
| 29-243-0 |
l-Aspartic acid, bis(trimethylsilyl) ester
|
|
2 | 1.460 |
| 29-405-0 |
GA39 3-isovalerate, methyl ester TMS
|
|
2 | 4.688 |
| 29-433-9 |
[14C] GA30 methyl ester TMS ether
|
|
2 | 4.690 |
| 29-557-2 |
GA3-isolactone, methyl ester TMS ether
|
|
2 | 5.058 |
| 29-583-3 |
16«alpha»-HydroxyDHEA (ii), MO TMS
|
|
2 | 7.082 |
| 29-671-5 |
p-Hydroxynorephedrine, N-TFA-O-TMS
|
|
2 | 4.860 |
| 29-730-9 |
7«beta»-Hydroxy kaurenoic acid, TMS
|
|
2 | 7.164 |
| 29-837-1 |
GLUCO-GULO-HEPTOSE MEOX 6TMS-2
|
|
2 | 7.571 |
| 29-912-7 |
Ala-Gly, N-trimethylsilyl-, trimethylsilyl ester
|
|
2 | 1.294 |
| 30-140-2 |
3,5-Dichlorobenzyl alcohol, bromomethyldimethylsilyl ether
|
|
2 | 4.649 |
| 30-153-8 |
«alpha»-D(+)-Fucose, pyranose, TMS
|
|
2 | 6.032 |
| 30-193-4 |
[14C] GA44 methyl ester TMS ether
|
|
2 | 4.476 |
| 30-232-0 |
Ceramide 18:1/24:1 methaneboronate
|
|
2 | 13.640 |
| 30-362-6 |
Oxamide, n-[3-(1-aziridinyl)propyl]-
|
24480-30-6 |
2 | -1.706 |
| 30-548-0 |
N,N',o-Tris-(trimethylsilyl)lysine
|
7415-18-1 |
2 | 3.752 |
| 30-664-1 |
Galacturonic acid, 1-MO, 5TMS, MP
|
|
2 | 5.877 |
| 30-665-0 |
Glucuronic acid, 1-MO, 5TMS, BP
|
|
2 | 5.877 |
|
« Previous Results
Next Results »
|